[ad_1]
Tampa General Hospital Cancer Institute’s new state-of-the-art unit advances treatment for patients with aggressive cancers.
TAMPA, Fla., Oct. 3, 2022 /PRNewswire/ — As part of its commitment to world-class, innovative cancer care for the Tampa Bay region and beyond, Tampa General Hospital (TGH) Cancer Institute has established an adult Bone Marrow Transplant (BMT) and Cell Therapies unit that focuses on treating patients with aggressive blood cancers such as leukemias, lymphomas, multiple myeloma as well as other cancers.
“As we continue to build a Cancer Institute that is at the forefront of innovative treatments for patients with complex cancers, the establishment of our state-of-the-art BMT and Cell Therapies Unit will broaden the portfolio of groundbreaking and life-saving treatment options for cancer patients in our state and beyond,” said Dr. Eduardo M. Sotomayordirector of the TGH Cancer Institute and an internationally recognized pioneer in the fields of cancer immunology and immunotherapy and hematologic tumors. “For many years, we have known of the life-saving properties of stem cells. However, we are just beginning to realize the power of an emerging field known as cell therapies. In our BMT and Cell Therapies unit, we aim to provide these therapies as well as make groundbreaking contributions to the field through innovative research.”
Bone marrow transplant (BMT), also known as stem cell therapy (SCT), is a proven treatment for patients with cancers of the blood for which the standard treatments have not been effective or those who have a high risk of …
Full story available on Benzinga.com
[ad_2]
Source link
